Testing the acceptability and feasibility of a tablet-based supportive cancer platform for patients with metastatic breast cancer

Addressing metastatic individuals everyday: Rationale and design of the nurse AMIE for Amazon Echo Show trial among metastatic breast cancer patients

“…Patient acceptability was defined as the percentage of eligible and approached participants agreeing to participate in the intervention. We observed an acceptability of 68% with the tablet-based Nurse AMIE intervention, and we hypothesized the Nurse AMIE for Amazon Echo Show version would have a comparable or higher acceptability rate [ 8 ]. We defined feasibility the same as the tablet-based Nurse AMIE intervention: participating in at least 30 of the first 90 days.…”

“…Additionally, prior research indicated patients desired a nutrition component be added to Nurse AMIE [ 7 ]. Technology may be a useful tool to assess and address the needs of MBC patients, including options to enhance patient-provider communication, and provide guideline-concordant self-care interventions to reduce symptom burden [ 8 ]. These technologies take many shapes and forms, and the best ways to use technology to serve the needs of MBC patients are unclear.…”

“…These technologies take many shapes and forms, and the best ways to use technology to serve the needs of MBC patients are unclear. In prior research, we developed a tablet-based supportive care platform called Nurse AMIE (Addressing Metastatic Individuals Everyday) [ 8 ]. It was observed to be feasible and acceptable; patients reported liking the interventions offered on the tablet 83% of the time [ 8 ].…”

“…In prior research, we developed a tablet-based supportive care platform called Nurse AMIE (Addressing Metastatic Individuals Everyday) [ 8 ]. It was observed to be feasible and acceptable; patients reported liking the interventions offered on the tablet 83% of the time [ 8 ]. However, in this prior work, some MBC patients we approached for the Nurse AMIE intervention declined to participate because they felt overwhelmed by the tablet technology.…”

Introduction to special section: Living with Incurable Cancer: Addressing Gaps in Cancer Survivorship

“…Likewise, Hunt et al [12] found that patients who participate in phase I clinical trials reported psychological distress, suggesting that provision of services for patients at enrollment is needed. Beatty et al [13] and Schmitz et al [14] describe the development of digital technology to support symptom management and provide psychosocial care for women living with metastatic cancer. We look forward to further testing of these interventions in larger trials.…”